BLOG

Japan’s Regenerative Medicine Law and Stem Cell Therapy: What to Ask Before Visiting

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are an international patient considering adipose-derived stem cell therapy in Japan, you will quickly notice that the treatment is described in terms of a legal framework as well as a medical one. Terms such as the Act on the Safety of Regenerative Medicine and a regenerative medicine provision plan appear on clinic websites, yet they are rarely explained. This article describes, in plain language, what these terms generally mean and which questions may help you prepare for a consultation at Grand Green Osaka Umekita Clinic or any other clinic.

Please note that this is general information, not medical advice. Adipose-derived stem cell therapy is provided as a self-pay treatment that is not covered by Japanese public health insurance, and whether it is appropriate for you must be decided with a physician after an individual consultation.

The short answer: Japan regulates regenerative medicine by process, not just by product

In Japan, regenerative medicine provided to patients at clinics is overseen under the Act on the Safety of Regenerative Medicine. In general terms, a medical institution that wants to offer a given regenerative treatment must prepare a provision plan describing how the treatment will be delivered. That plan is reviewed by a certified committee and then submitted to the Ministry of Health, Labour and Welfare. Cell culture and processing are expected to take place at facilities that are themselves registered or licensed under the same system.

The purpose of this structure is to place procedures, facilities and oversight under defined rules. It does not mean that a treatment has been proven to work for every patient, and it should not be read as an assurance of any particular result. Think of it as a framework that helps you ask better questions, not as a substitute for them.

What a provision plan can tell you about a treatment

A provision plan is, roughly speaking, the written description of what a clinic is permitted to offer under the system. Plans are made for specific treatments, and the scope of each plan matters. A clinic that is authorized to provide one kind of cell therapy has not automatically been authorized to provide every other kind.

For adipose-derived stem cell therapy, the clinic’s explanation typically touches on several practical elements. You may wish to ask your physician how each of them applies to your situation:

  • The cell source: your own fat tissue, collected in a small outpatient procedure under local anesthesia.
  • The processing step: mesenchymal stem cells are cultured and expanded at a specialized facility before being returned to you.
  • The administration method: in this treatment, the cultured cells are given by intravenous infusion on an outpatient basis.
  • The conditions the clinic can discuss: the scope of the plan determines what a clinic may offer, so ask which uses are covered.
  • The reporting arrangements: clinics are expected to monitor treatments and report certain events to the authorities.

Asking a clinic to explain these points in your own language is reasonable. A well-organized explanation, together with time to ask questions, is generally a good sign of a careful consultation.

Questions about the cell processing facility

Because your cells are cultured outside the clinic, the processing facility is an important part of the overall picture. Under the Japanese framework, cell processing is expected to be carried out at facilities that meet defined standards for hygiene, quality control and record keeping. As a patient you are not expected to inspect a laboratory, but you can reasonably ask about the following:

  • Whether the facility is registered or licensed under the Japanese system, and where it is located.
  • How your cells are identified and tracked so that your own cells are returned to you.
  • How long the culture period is expected to take, and what happens if the cells do not grow as planned.
  • What quality checks are performed before the cells are used.

Culture time affects scheduling, which is especially relevant if you are traveling from overseas. Your care team can explain the typical sequence of visits so that you can plan your stay and your return home with realistic expectations.

Risks, limits and the role of your own doctor

Even within a regulated system, every medical treatment carries potential risks. Fat collection may cause bruising, discomfort or infection at the collection site. Intravenous infusion may cause reactions in some people. Because you are receiving your own cells, the likelihood of rejection is considered lower than with donor cells, but this does not remove the need for careful screening and follow-up.

It is also important to understand the state of the evidence. Research on mesenchymal stem cells is active worldwide, and some effects, such as the secretion of anti-inflammatory substances and growth factors, have been reported in studies. However, results differ by condition, and published findings should not be generalized to every patient. A regenerative treatment is not a replacement for standard medical care. If you are being treated for a condition at home, please talk with your regular doctor before deciding, and bring your medical records and medication list to the consultation in Osaka.

Your physician will review your history, current health and goals, and may advise that the treatment is not suitable for you. Costs, expected treatment schedule, risks and side effects should all be confirmed in that consultation before you decide to proceed.

Preparing for a consultation in Osaka as an international patient

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka and offers an information page for international patients, so that people living abroad and foreign residents of Japan can review the basic flow of treatment in advance. Reading that page, and the adipose-derived stem cell therapy page, before your visit can help you arrive with focused questions.

The following checklist may be useful when you prepare:

  • Write down your diagnosis, current medications and any allergies, and ask your home doctor for a summary letter if possible.
  • Ask which language support is available during the consultation and for written consent documents.
  • Request a written explanation of fees, the schedule of visits, risks and possible side effects.
  • Ask how follow-up will be handled after you return to your home country, and whom to contact if you have concerns.
  • Take your time. You are free to decide not to proceed, or to think it over before making a decision.

In summary, understanding that adipose-derived stem cell therapy in Japan is provided under a legal framework with a provision plan and defined processing standards can help you ask informed questions. It does not predict how any individual will respond. A consultation with a qualified physician remains the essential step for deciding whether this self-pay regenerative treatment fits your circumstances.

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact